Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Periodontal Disease in Patients Receiving Dialysis.

Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A, Sakai H.

Int J Mol Sci. 2019 Aug 3;20(15). pii: E3805. doi: 10.3390/ijms20153805. Review.

2.

Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation.

Kitamura M, Mochizuki Y, Miyata Y, Obata Y, Mitsunari K, Matsuo T, Ohba K, Mukae H, Yoshimura A, Nishino T, Sakai H.

Int J Mol Sci. 2019 Jul 11;20(14). pii: E3413. doi: 10.3390/ijms20143413. Review.

3.

A Review of Oxidative Stress and Urinary Dysfunction Caused by Bladder Outlet Obstruction and Treatments Using Antioxidants.

Miyata Y, Matsuo T, Mitsunari K, Asai A, Ohba K, Sakai H.

Antioxidants (Basel). 2019 May 15;8(5). pii: E132. doi: 10.3390/antiox8050132. Review.

4.

The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.

Nakamura Y, Miyata Y, Takehara K, Asai A, Mitsunari K, Araki K, Matsuo T, Ohba K, Sakai H.

Anticancer Res. 2019 May;39(5):2317-2324. doi: 10.21873/anticanres.13348.

PMID:
31092423
5.

Efficacy and safety of sunitinib alternate day regimen in patients with metastatic renal cell carcinoma in Japan: Comparison with standard 4/2 schedule.

Ohba K, Miyata Y, Yasuda T, Asai A, Mitsunari K, Matsuo T, Mochizuki Y, Matsunaga N, Sakai H.

Asia Pac J Clin Oncol. 2018 Jun;14(3):153-158. doi: 10.1111/ajco.12849. Epub 2018 Jan 31.

PMID:
29383843
6.

Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival.

Mitsunari K, Miyata Y, Watanabe SI, Asai A, Yasuda T, Kanda S, Sakai H.

Oncol Lett. 2017 Feb;13(2):834-840. doi: 10.3892/ol.2016.5481. Epub 2016 Dec 12.

7.

Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.

Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H.

Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12.

8.
9.

Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer.

Mitsunari K, Miyata Y, Asai A, Matsuo T, Shida Y, Hakariya T, Sakai H.

Transl Res. 2016 Sep;175:116-28. doi: 10.1016/j.trsl.2016.04.002. Epub 2016 Apr 29.

10.

Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer.

Miyata Y, Asai A, Mitsunari K, Matsuo T, Ohba K, Sakai H.

Med Oncol. 2015 Oct;32(10):235. doi: 10.1007/s12032-015-0683-y. Epub 2015 Aug 27.

11.

[Clinical analysis of non-clear cell renal cell carcinoma].

Ohba K, Asai A, Mitsunari K, Matsuo T, Mochizuki Y, Miyata Y, Sakai H.

Hinyokika Kiyo. 2015 Feb;61(2):43-7. Japanese.

12.

Smoking-induced changes in cancer-related factors in patients with upper tract urothelial cancer.

Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Mochizuki Y, Sakai H.

Mol Clin Oncol. 2015 Mar;3(2):287-294. Epub 2014 Dec 2.

13.

Met in urological cancers.

Miyata Y, Asai A, Mitsunari K, Matsuo T, Ohba K, Mochizuki Y, Sakai H.

Cancers (Basel). 2014 Dec 16;6(4):2387-403. doi: 10.3390/cancers6042387. Review.

14.

Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.

Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H.

Prostate. 2015 Jan;75(1):84-91. doi: 10.1002/pros.22894. Epub 2014 Oct 13.

15.

Left atrial metastasis of renal cell carcinoma: a case report and review of the literature.

Ohba K, Miyata Y, Mitsunari K, Matsuo T, Mochizuki Y, Sakai H.

BMC Res Notes. 2014 Aug 12;7:520. doi: 10.1186/1756-0500-7-520. Review.

16.

Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity.

Miyata Y, Kanda S, Mitsunari K, Asai A, Sakai H.

Transl Res. 2014 Dec;164(6):468-76. doi: 10.1016/j.trsl.2014.06.010. Epub 2014 Jul 3.

17.

High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.

Ohba K, Miyata Y, Matsuo T, Asai A, Mitsunari K, Shida Y, Kanda S, Sakai H.

Int J Clin Exp Pathol. 2014 May 15;7(6):3158-65. eCollection 2014.

18.

High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer.

Miyata Y, Watanabe S, Sagara Y, Mitsunari K, Matsuo T, Ohba K, Sakai H.

PLoS One. 2013;8(3):e59095. doi: 10.1371/journal.pone.0059095. Epub 2013 Mar 13.

Supplemental Content

Loading ...
Support Center